Paul Holmes 11 Feb 2003 // 12:00AM GMT
NEW YORK—Edelman has formalized an international life sciences practice to provide communications services to companies and organizations in high-technology healthcare sectors including established and emerging biotechnology, biopharmaceuticals, biomedical research, medical devices, medical diagnostics, and health technology.
The practice includes specialists in the United States and in Europe, with access to the firm’s teams in health, corporate, financial, and public affairs. It brings together the firm’s existing life sciences expertise, which includes experience in biotechnology (Cerus Corporation) and medical devices (Aspect Medical Systems) to involvement in market-growing industry initiatives, such as the Biovision and Biotechnica conferences.
“The future of health is the research and development of life-saving products and technologies, and the magnitude of this rapidly growing industry requires a dedicated practice,” says Nancy Turett, president and global director of health. “The launch of Edelman Life Sciences underscores the breadth and depth of the firm’s offerings and demonstrates our commitment to leading in this sector, which in turn will cultivate all of our other health practices.”
Dedicated group heads are Amy Martini and Lorie Fiber. Martini, senior vice president and director of life sciences on the east coast, has more than 12 years of experience in the biotech industry. Before joining Edelman, Martini served as general manager of financial communications, at Noonan/Russo. Fiber, senior vice president and director of life sciences on the west coast, was previously senior VP at FischerHealth.